Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: men mailman who wrote (1267)	3/11/1998 1:31:00 PM
From: men mailman	Respond to of 2068

Small volume today.Saw ineresting article that the Magellin fund is investing in the healthcare sector (see end of post). Even if Magellin did not buy OXHP specifically (btw Fidelity still owns 1.8 mil. shares) it does show they expect the healthcare sector to do well in the near future, be it by boost in earnings expectations or consolidation and merger expectation. If you feel like I do that the worst for oxhp is behind us then OXHP will probably outperform other healthcare issues. Here is excerpt of article. "Magellan Fund raised its holdings in technology and health care stocks in January, but cut assets invested in finance and energy shares. The massive fund raised the percentage of its assets invested in tech stocks to 15.1 percent as of Jan. 31, compared with 12.9 percent Dec. 31. The fund also raised its total investments in equities to 95.1 percent of assets at the end of January from 93.7 percent at the end of December, according to the Fidelity's monthly Mutual Fund Guide, released Wednesday. "" ÿ